KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 158 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $622,123 | -31.0% | 347,555 | +31.0% | 0.00% | -33.3% |
| Q4 2022 | $902,047 | -27.7% | 265,308 | +16.2% | 0.00% | -25.0% |
| Q3 2022 | $1,247,000 | -73.0% | 228,335 | -77.7% | 0.00% | -73.3% |
| Q2 2022 | $4,617,000 | -44.0% | 1,023,752 | -8.4% | 0.02% | -37.5% |
| Q1 2022 | $8,239,000 | +29.6% | 1,117,925 | +13.0% | 0.02% | +71.4% |
| Q4 2021 | $6,359,000 | -0.4% | 989,031 | -9.8% | 0.01% | 0.0% |
| Q3 2021 | $6,383,000 | -26.9% | 1,096,683 | +29.6% | 0.01% | -30.0% |
| Q2 2021 | $8,732,000 | -44.4% | 846,118 | -43.3% | 0.02% | -51.2% |
| Q1 2021 | $15,703,000 | +2424.6% | 1,492,642 | +3611.9% | 0.04% | +1950.0% |
| Q4 2020 | $622,000 | -96.7% | 40,212 | -96.9% | 0.00% | -97.0% |
| Q3 2020 | $18,800,000 | +321.1% | 1,287,652 | +446.2% | 0.07% | +204.5% |
| Q2 2020 | $4,465,000 | -46.9% | 235,734 | -46.1% | 0.02% | -67.6% |
| Q1 2020 | $8,407,000 | -41.8% | 437,622 | -41.9% | 0.07% | +58.1% |
| Q4 2019 | $14,441,000 | +6809.6% | 753,334 | +3368.7% | 0.04% | +4200.0% |
| Q3 2019 | $209,000 | -43.7% | 21,718 | -64.9% | 0.00% | 0.0% |
| Q2 2019 | $371,000 | -81.7% | 61,904 | -82.1% | 0.00% | -85.7% |
| Q1 2019 | $2,025,000 | -64.6% | 346,787 | -43.3% | 0.01% | -68.2% |
| Q4 2018 | $5,727,000 | -15.7% | 611,153 | +53.2% | 0.02% | +15.8% |
| Q3 2018 | $6,794,000 | -20.8% | 398,957 | -21.0% | 0.02% | -26.9% |
| Q2 2018 | $8,577,000 | +424.3% | 504,809 | +314.2% | 0.03% | +420.0% |
| Q1 2018 | $1,636,000 | +602.1% | 121,888 | +403.3% | 0.01% | +400.0% |
| Q4 2017 | $233,000 | +55.3% | 24,220 | +76.8% | 0.00% | 0.0% |
| Q3 2017 | $150,000 | – | 13,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $35,031,000 | 23.03% |
| Palo Alto Investors LP | 5,267,652 | $81,543,000 | 4.28% |
| Fairmount Funds Management LLC | 702,351 | $10,872,000 | 3.89% |
| Birchview Capital, LP | 188,000 | $2,910,000 | 1.68% |
| Mesirow Financial Investment Management, Inc. | 22,303 | $345,250,000 | 1.09% |
| EMERALD ADVISERS, LLC | 1,822,781 | $28,217,000 | 0.94% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,661,236 | $25,716,000 | 0.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,552,504 | $24,033,000 | 0.85% |
| Altium Capital Management LP | 133,951 | $2,074,000 | 0.77% |
| Hood River Capital Management LLC | 931,754 | $14,424,000 | 0.48% |